161 related articles for article (PubMed ID: 15961375)
1. Mitochondrial permeability transition pore as a target for cardioprotection in the human heart.
Shanmuganathan S; Hausenloy DJ; Duchen MR; Yellon DM
Am J Physiol Heart Circ Physiol; 2005 Jul; 289(1):H237-42. PubMed ID: 15961375
[TBL] [Abstract][Full Text] [Related]
2. Transient mitochondrial permeability transition pore opening mediates preconditioning-induced protection.
Hausenloy D; Wynne A; Duchen M; Yellon D
Circulation; 2004 Apr; 109(14):1714-7. PubMed ID: 15066952
[TBL] [Abstract][Full Text] [Related]
3. Inhibiting mitochondrial permeability transition pore opening at reperfusion protects against ischaemia-reperfusion injury.
Hausenloy DJ; Duchen MR; Yellon DM
Cardiovasc Res; 2003 Dec; 60(3):617-25. PubMed ID: 14659807
[TBL] [Abstract][Full Text] [Related]
4. Sanglifehrin A acts as a potent inhibitor of the mitochondrial permeability transition and reperfusion injury of the heart by binding to cyclophilin-D at a different site from cyclosporin A.
Clarke SJ; McStay GP; Halestrap AP
J Biol Chem; 2002 Sep; 277(38):34793-9. PubMed ID: 12095984
[TBL] [Abstract][Full Text] [Related]
5. Nanoparticle-Mediated Targeting of Cyclosporine A Enhances Cardioprotection Against Ischemia-Reperfusion Injury Through Inhibition of Mitochondrial Permeability Transition Pore Opening.
Ikeda G; Matoba T; Nakano Y; Nagaoka K; Ishikita A; Nakano K; Funamoto D; Sunagawa K; Egashira K
Sci Rep; 2016 Feb; 6():20467. PubMed ID: 26861678
[TBL] [Abstract][Full Text] [Related]
6. Age-associated differences in the inhibition of mitochondrial permeability transition pore opening by cyclosporine A.
Liu L; Zhu J; Brink PR; Glass PS; Rebecchi MJ
Acta Anaesthesiol Scand; 2011 May; 55(5):622-30. PubMed ID: 21827445
[TBL] [Abstract][Full Text] [Related]
7. Ischaemic preconditioning inhibits opening of mitochondrial permeability transition pores in the reperfused rat heart.
Javadov SA; Clarke S; Das M; Griffiths EJ; Lim KH; Halestrap AP
J Physiol; 2003 Jun; 549(Pt 2):513-24. PubMed ID: 12692185
[TBL] [Abstract][Full Text] [Related]
8. Oxidative stress, mitochondrial permeability transition pore opening and cell death during hypoxia-reoxygenation in adult cardiomyocytes.
Assaly R; de Tassigny Ad; Paradis S; Jacquin S; Berdeaux A; Morin D
Eur J Pharmacol; 2012 Jan; 675(1-3):6-14. PubMed ID: 22173126
[TBL] [Abstract][Full Text] [Related]
9. Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning?
Hausenloy DJ; Maddock HL; Baxter GF; Yellon DM
Cardiovasc Res; 2002 Aug; 55(3):534-43. PubMed ID: 12160950
[TBL] [Abstract][Full Text] [Related]
10. Cyclosporin A and cardioprotection: from investigative tool to therapeutic agent.
Hausenloy DJ; Boston-Griffiths EA; Yellon DM
Br J Pharmacol; 2012 Mar; 165(5):1235-45. PubMed ID: 21955136
[TBL] [Abstract][Full Text] [Related]
11. Morphine-Induced Preconditioning: Involvement of Protein Kinase A and Mitochondrial Permeability Transition Pore.
Dorsch M; Behmenburg F; Raible M; Blase D; Grievink H; Hollmann MW; Heinen A; Huhn R
PLoS One; 2016; 11(3):e0151025. PubMed ID: 26968004
[TBL] [Abstract][Full Text] [Related]
12. Transient opening of mitochondrial permeability transition pore by reactive oxygen species protects myocardium from ischemia-reperfusion injury.
Saotome M; Katoh H; Yaguchi Y; Tanaka T; Urushida T; Satoh H; Hayashi H
Am J Physiol Heart Circ Physiol; 2009 Apr; 296(4):H1125-32. PubMed ID: 19202002
[TBL] [Abstract][Full Text] [Related]
13. Tissue kallikrein is required for the cardioprotective effect of cyclosporin A in myocardial ischemia in the mouse.
Youcef G; Belaidi E; Waeckel L; Fazal L; Clemessy M; Vincent MP; Zadigue G; Richer C; Alhenc-Gelas F; Ovize M; Pizard A
Biochem Pharmacol; 2015 Mar; 94(1):22-9. PubMed ID: 25623731
[TBL] [Abstract][Full Text] [Related]
14. Preconditioning and postconditioning: the essential role of the mitochondrial permeability transition pore.
Lim SY; Davidson SM; Hausenloy DJ; Yellon DM
Cardiovasc Res; 2007 Aug; 75(3):530-5. PubMed ID: 17512507
[TBL] [Abstract][Full Text] [Related]
15. Extracellular Cl
Zhang XG; Zhao L; Zhang Y; Li YY; Wang H; Duan GL; Xiao L; Li XR; Chen HP
Biomed Pharmacother; 2017 Feb; 86():637-644. PubMed ID: 28033580
[TBL] [Abstract][Full Text] [Related]
16. Slow calcium waves and redox changes precede mitochondrial permeability transition pore opening in the intact heart during hypoxia and reoxygenation.
Davidson SM; Yellon DM; Murphy MP; Duchen MR
Cardiovasc Res; 2012 Mar; 93(3):445-53. PubMed ID: 22198507
[TBL] [Abstract][Full Text] [Related]
17. A Phenyl-Pyrrolidine Derivative Reveals a Dual Inhibition Mechanism of Myocardial Mitochondrial Permeability Transition Pore, Which Is Limited by Its Myocardial Distribution.
Panel M; Ahmed-Belkacem A; Ruiz I; Guichou JF; Pawlotsky JM; Ghaleh B; Morin D
J Pharmacol Exp Ther; 2021 Mar; 376(3):348-357. PubMed ID: 33303698
[TBL] [Abstract][Full Text] [Related]
18. Danhong injection protects cardiomyocytes against hypoxia/reoxygenation- and H2O2-induced injury by inhibiting mitochondrial permeability transition pore opening.
Duan ZZ; Li YH; Li YY; Fan GW; Chang YX; Yu B; Gao XM
J Ethnopharmacol; 2015 Dec; 175():617-25. PubMed ID: 26320687
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial permeability transition pore opening during myocardial reperfusion--a target for cardioprotection.
Halestrap AP; Clarke SJ; Javadov SA
Cardiovasc Res; 2004 Feb; 61(3):372-85. PubMed ID: 14962470
[TBL] [Abstract][Full Text] [Related]
20. Opening of mitochondrial permeability transition pore induces hypercontracture in Ca2+ overloaded cardiac myocytes.
Ruiz-Meana M; Abellán A; Miró-Casas E; Garcia-Dorado D
Basic Res Cardiol; 2007 Nov; 102(6):542-52. PubMed ID: 17891523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
